2-(2-(苄氧基羰基氨基)丙-2-基)-5-羟基-6-氧代-1,6-二氢嘧啶-4-甲酸甲酯
中文名称 | 2-(2-(苄氧基羰基氨基)丙-2-基)-5-羟基-6-氧代-1,6-二氢嘧啶-4-甲酸甲酯 |
---|---|
中文同义词 | 2-(2-(苄氧基羰基氨基)丙-2-基)-5-羟基-6-氧代-1,6-二氢嘧啶-4-甲酸甲酯(雷特格韦中间体);雷特格韦中间体D;2-(2-(苄氧基羰基氨基)丙-2-基)-5-羟基-6-氧代-1,6-二氢嘧啶-4-甲酸甲酯;雷特格韦-RT5;2-(2-(苄氧基羰基氨基)丙-2-基)-5-羟基-6-氧代-1,6-二氢嘧啶-4-甲酸甲酯(雷特格韦中间体片段-2) 1KG;2-(2-(苄氧基羰基氨基)丙-2-基)-5-羟基-6-氧代一1,6-二氢嘧啶-4-甲酸甲酯(雷特格韦);雷特格韦中间体E;雷特格韦中间体N-4 |
英文名称 | 4-PYRIMIDINECARBOXYLIC ACID, 1,6-DIHYDRO-5-HYDROXY-2-[1-METHYL-1-[[(PHENYLMETHOXY)CARBONYL]AMINO]ETHYL]-6-OXO-, METHYL ESTER |
英文同义词 | InterMediate E of Raltegravir;2-(2-(BenzyloxycarbonylaMino)propan-2-yl)-5-hydroxy-6-oxo-1,6-dihydropyriMidine-4-Methyl forMate;Methyl2-(1-{[(benzyloxy)carbonyl]aMino}-1-Methylethyl)-5,6-dihydroxypyriMidine-4-carboxyllate;Methyl 2-(2-(benzyloxycarbonyl)propan-2-yl)-5-hydroxy-6-oxo-1,6-dihydropyriMidine-4-carboxylate;Methyl-2-(2-{[(benzyloxy)carbo;Methyl 2-(2-(benzyloxycarbonylamino)propan-2-yl)-5-hydroxy-6-oxo-l,6-dihydropyrimidine-4-carboxylate(Raltegravir);4-PYRIMIDINECARBOXYLIC ACID, 1,6-DIHYDRO-5-HYDROXY-2-[1-METHYL-1-[[(PHENYLMETHOXY)CARBONYL]AMINO]ETHYL]-6-OXO-, METHYL ESTER;1,6-Dihydro-5-hydroxy-2-[1-methyl-1-[[benzylcarbamoyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxylic Acid Methyl Ester |
CAS号 | 519032-08-7 |
分子式 | C17H19N3O6 |
分子量 | 361.35 |
EINECS号 | 917-658-8 |
相关类别 | 医药中间体;拉替拉韦中间体;Heterocycle-Pyrimidine series;Amines;Aromatics;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals |
Mol文件 | 519032-08-7.mol |
结构式 |
2-(2-(苄氧基羰基氨基)丙-2-基)-5-羟基-6-氧代-1,6-二氢嘧啶-4-甲酸甲酯 性质
熔点 | 186.3-187.0 °C |
---|---|
密度 | 1.34±0.1 g/cm3(Predicted) |
储存条件 | 2-8°C |
溶解度 | 可溶于DMSO(少许)、甲醇(少许) |
酸度系数(pKa) | 4.50±1.00(Predicted) |
形态 | 固体 |
颜色 | 白色至类白色 |
2-(2-(苄氧基羰基氨基)丙-2-基)-5-羟基-6-氧代-1,6-二氢嘧啶-4-甲酸甲酯用于制备HIV整合酶抑制剂的中间体。
安全信息
危险等级 | IRRITANT |
---|